自从慢性高血压和怀孕试验以来,新兴的概念
Michal Fishel Bartal1, George Saade2, Alan T Tita3
1Division of Maternal-Fetal Medicine, Department of Obstetrics, Gynecology, and Reproductive Sciences, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX; Department of Obstetrics and Gynecology, Sheba Medical Center, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
American journal of obstetrics and gynecology
|June 1, 2023
概括
该CHAP试验为在怀孕期间管理轻度慢性高血压提供了新的指导. 本临床意见阐明了试验实施,并解决了怀孕期间管理高血压的临床问题.
科学领域:
- 产科和妇科 产科和妇科
- 孕产妇和胎儿医学 孕产妇和胎儿医学
- 怀孕中的心脏病学
背景情况:
- 怀孕期间轻度慢性高血压会影响母亲和胎儿的结果.
- 最近的慢性高血压和怀孕 (CHAP) 试验结果影响了临床管理.
- 实施新的试验结果可能会带来挑战.
研究的目的:
- 澄清实施CHAP试验结果的实际方面.
- 为解决CHAP试验所产生的临床问题,以管理怀孕期间的慢性高血压.
- 为患者管理提供专家意见和建议.
主要方法:
- 基于专家经验的临床意见.
- 试验进行细节的讨论不在主要手稿中.
- 分析潜在的临床情景和管理策略.
主要成果:
- 该CHAP试验提供了治疗怀孕期间轻度慢性高血压的证据.
- 实施需要解决实际管理和临床问题.
- 专家意见提供了超出试验数据的指导.
结论:
- 该CHAP试验代表了在怀孕期间管理轻度慢性高血压的重大转变.
- 本意见澄清了实施细节,并解决了关键的临床问题.
- 提供了指导,以支持临床医生将试验结果应用于患者护理.
相关概念视频
Hypertension III: Clinical Manifestations and Diagnostic Studies
35
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
35
Hypertension II: Pathophysiology
23
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
23
Hypertension I: Introduction
27
Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
27
Hypertension and Regulation of Blood Pressure
2.1K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
2.1K
Hypertension V: Nursing Management
13
The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
13
Hypertension IV: Drug Therapy and Lifestyle Modifications
20
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
20


